
Full text loading...
Category: Clinical Microbiology
Human Papillomavirus, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555819040/9781555819033_Chap08-1.gif /docserver/preview/fulltext/10.1128/9781555819040/9781555819033_Chap08-2.gifAbstract:
Human papillomavirus (HPV), a member of the Papillomaviridae family, is a small (8kb), nonenveloped, double-stranded DNA virus. HPV has a predilection for infecting cutaneous and mucosal epithelial cells ( 1 ). Infection with HPV is associated with a wide range of pathology. HPV is the etiological factor in benign cutaneous warts and juvenile respiratory papillomatosis, as well as low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL), a precursor to cancer, and invasive carcinoma ( 2 ). Harald zur Hausen, a German virologist, was the first to describe the association of HPV and cervical cancer in the 1970s ( 3 , 4 ). It is now understood that HPV is necessary in the development of cervical cancer and is also associated with carcinoma of the vulva, vagina, penis, anus, and oropharynx ( 5 , 6 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Full text loading...
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Algorithm for diagnosis of oropharyngeal squamous cell carcinoma.
Algorithm for diagnosis of oropharyngeal squamous cell carcinoma.
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Algorithm for screening and diagnosis of anal cancer in high-risk groups. There are currently no formal recommendations for routine anal cancer screening in the United States.
Algorithm for screening and diagnosis of anal cancer in high-risk groups. There are currently no formal recommendations for routine anal cancer screening in the United States.
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Algorithm for screening and diagnosis of cervical cancer in immunosuppressed women. For HIV-infected women ( 90 ), screen at 6 months, 12 months, then annually; consider screening within 1 year of onset of sexual activity ( 92 ); some experts would recommend continued cytology screening every 6 months in women with CD4 counts less than 200/mm3 or a history of HPV infection. For immunosuppressed women without HIV, annual cervical cytology screening is recommended ( 90 ).
Algorithm for screening and diagnosis of cervical cancer in immunosuppressed women. For HIV-infected women ( 90 ), screen at 6 months, 12 months, then annually; consider screening within 1 year of onset of sexual activity ( 92 ); some experts would recommend continued cytology screening every 6 months in women with CD4 counts less than 200/mm3 or a history of HPV infection. For immunosuppressed women without HIV, annual cervical cytology screening is recommended ( 90 ).
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Cytological and histological classification of anal dysplasia and cervical dysplasia a
Cytological and histological classification of anal dysplasia and cervical dysplasia a
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Cervical cancer screening guidelines
Cervical cancer screening guidelines
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015Role for HPV testing in HIV-infected women a ( 119 )
Diagnostic Microbiology of the Immunocompromised Host, Second Edition
. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.DMIH2-0001-2015